Clinical Trial Update: A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing US-marketed Creon from a modernized process at an alternate site and with the approved process at a different site in participants with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Creon (pancrelipase)

Snippet

Sponsor: AbbVie | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED | Results posted: 2023-09-28